Original Article

Inflammation and Immune-Based Scores Predict Prognosis for Patients with Hepatocellular Carcinoma: A Pilot Single-Center Study

Volume 36 · Issue 4 Publish Date: January 6, 2025
Full Text HTML PDF
DOI
Merve Guzel Dirim ORCID
Department of Internal Medicine, İstanbul University İstanbul Faculty of Medicine, İstanbul, Türkiye
Asli Cifcibasi Ormeci ORCID
Division of Gastr oente rohep atolo gy, Department of Internal Medicine, İstanbul University İstanbul Faculty of Medicine, İstanbul, Türkiye
Bilger Cavus ORCID
Division of Gastr oente rohep atolo gy, Department of Internal Medicine, İstanbul University İstanbul Faculty of Medicine, İstanbul, Türkiye
Arzu Poyanli ORCID
Department of Radiology, İstanbul University İstanbul Faculty of Medicine, İstanbul, Türkiye
Kursat Rahmi Serin ORCID
Department of General Surgery, İstanbul University İstanbul Faculty of Medicine, İstanbul, Türkiy
Filiz Akyuz ORCID
Division of Gastr oente rohep atolo gy, Department of Internal Medicine, İstanbul University İstanbul Faculty of Medicine, İstanbul, Türkiye
Kadir Demir ORCID
Division of Gastr oente rohep atolo gy, Department of Internal Medicine, İstanbul University İstanbul Faculty of Medicine, İstanbul, Türkiye
Selman Fatih Besisik ORCID
Division of Gastr oente rohep atolo gy, Department of Internal Medicine, İstanbul University İstanbul Faculty of Medicine, İstanbul, Türkiye
Sabahattin Kaymakoglu ORCID
Division of Gastr oente rohep atolo gy, Department of Internal Medicine, İstanbul University İstanbul Faculty of Medicine, İstanbul, Türkiye
Guzel Dirim, M., Cifcibasi Ormeci, A., Cavus, B., Poyanli, A., Serin, K. R., Akyuz, F., … Kaymakoglu, S. (2025). Inflammation and Immune-Based Scores Predict Prognosis for Patients with Hepatocellular Carcinoma: A Pilot Single-Center Study. Turkish Journal of Gastroenterology, 36(4), 219–228. https://doi.org/10.5152/tjg.2025.24407

Abstract

Background/Aims: Hepatocellular carcinoma (HCC) ranks as a major contributor to cancer-related deaths. Systemic inflammation plays a pivotal role in HCC development and progression. Thus, we aimed to determine the impact of inflammation- and immune-based scores in predicting the prognosis of HCC.

Materials and Methods: In this retrospective study, patients with HCC were enrolled between 2010 and 2020. The purpose of this ret rospective study was to evaluate the impact of various biomarkers, including baseline alpha fetoprotein (AFP) levels, C-reactive protein (CRP) –albu min–l ympho cyte (CALLY) index, neutrophil-to-CRP (N/CRP) ratio, systemic immune-inflammation index (SII), albumin–bili rubin (ALBI) score, neutr ophil -to-l ympho cyte ratio (NLR), and aspartate aminotransferase (AST)-to-alanine aminotransferase (ALT) (AST/ALT) ratio (AAR), on survival, invasion of vascular tracts, metastasis, and treatment responses.

Results: A total of 199 patients with complete (n = 44) and non-complete (n = 145) treatment response groups were enrolled in the study. All scores for the non-complete response group were statistically significant (P < .05). The areas under the curves for predicting a non-complete response group were 0.651, 0.649, 0.636, 0.625, 0.613, 0.609, and 0.600 for AFP, CALLY index, AAR, SII, N/CRP ratio, ALBI score, and NLR, respectively. These results are consistent with the assessment of mortality and HCC progression.

Conclusion: Our results indicate that these biomarkers could serve as powerful prognostic tools for HCC.

 

Cite this article as: Guzel Dirim M, Cifcibasi Ormeci A, Cavus B, et al. Inflammation and immune-based scores predict prognosis for patients with hepatocellular carcinoma: A pilot single-center study. Turk J Gastroenterol. 2025;36(4):219-228.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 > >> 
Article Info
Published In
Journal Turkish Journal of Gastroenterology
Volume / Issue Volume 36 · Issue 4
Pages 219-228
History
Published Online January 6, 2025
License
Copyright
Affiliations
Merve Guzel Dirim ORCID
Department of Internal Medicine, İstanbul University İstanbul Faculty of Medicine, İstanbul, Türkiye
Asli Cifcibasi Ormeci ORCID
Division of Gastr oente rohep atolo gy, Department of Internal Medicine, İstanbul University İstanbul Faculty of Medicine, İstanbul, Türkiye
Bilger Cavus ORCID
Division of Gastr oente rohep atolo gy, Department of Internal Medicine, İstanbul University İstanbul Faculty of Medicine, İstanbul, Türkiye
Arzu Poyanli ORCID
Department of Radiology, İstanbul University İstanbul Faculty of Medicine, İstanbul, Türkiye
Kursat Rahmi Serin ORCID
Department of General Surgery, İstanbul University İstanbul Faculty of Medicine, İstanbul, Türkiy
Filiz Akyuz ORCID
Division of Gastr oente rohep atolo gy, Department of Internal Medicine, İstanbul University İstanbul Faculty of Medicine, İstanbul, Türkiye
Kadir Demir ORCID
Division of Gastr oente rohep atolo gy, Department of Internal Medicine, İstanbul University İstanbul Faculty of Medicine, İstanbul, Türkiye
Selman Fatih Besisik ORCID
Division of Gastr oente rohep atolo gy, Department of Internal Medicine, İstanbul University İstanbul Faculty of Medicine, İstanbul, Türkiye
Sabahattin Kaymakoglu ORCID
Division of Gastr oente rohep atolo gy, Department of Internal Medicine, İstanbul University İstanbul Faculty of Medicine, İstanbul, Türkiye
Cite this Article
Guzel Dirim, M., Cifcibasi Ormeci, A., Cavus, B., Poyanli, A., Serin, K. R., Akyuz, F., … Kaymakoglu, S. (2025). Inflammation and Immune-Based Scores Predict Prognosis for Patients with Hepatocellular Carcinoma: A Pilot Single-Center Study. Turkish Journal of Gastroenterology, 36(4), 219–228. https://doi.org/10.5152/tjg.2025.24407
Outlines